Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1IIIB Gag-Pol-Nef proteins of clade B-Reference-Cited by-同舟云学术

Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1IIIB Gag-Pol-Nef proteins of clade B

Published:2007-04 Issue:15 Volume:25 Page:2863-2885
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Gómez Carmen Elena,Nájera Jose Luis,Jiménez Eva Pérez,Jiménez Victoria,Wagner Ralf,Graf Marcus,Frachette Marie-Joelle,Liljeström Peter,Pantaleo Giuseppe,Esteban Mariano

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference46 articles.

1. Can we reverse the HIV/AIDS pandemic with an expanded response?;Stover;Lancet,2002

2. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody;Kwong;Nature,1998

3. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens;Wyatt;Science,1998

4. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine;Amara;Science,2001

5. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination;Barouch;Science,2000

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Highly Attenuated Poxvirus-Based Vaccines Against Emerging Viral Diseases;Journal of Molecular Biology;2023-08

2. An MVA-based vector expressing cell-free ISG15 increases IFN-I production and improves HIV-1-specific CD8 T cell immune responses;Frontiers in Cellular and Infection Microbiology;2023-05-29

3. Glycosylated protein 4-deficient PRRSV in complementing cell line shows low virus titer;Research in Veterinary Science;2023-05

4. The use of viral vectors in vaccine development;npj Vaccines;2022-07-04

5. HIV-1 therapeutic vaccines in clinical development to intensify or replace antiretroviral therapy: the promising results of the Tat vaccine;Expert Review of Vaccines;2022-06-17